公开(公告)号：EP2272522A2

公开(公告)日：2011-01-12

申请号：EP09157883.1

申请日：2003-06-30

申请人： Glykos Finland Oy

发明人： Angström, Jonas ,  Teneberg, Susann ,  Saarinen, Juhani ,  Satomaa, Tero ,  Roche, Niamh ,  Natunen, Jari ,  Miller-Podraza, Halina ,  Karlsson, Karl-Anders ,  Abul-Milh, Maan

IPC分类号： A61K31/702 ,  A61K35/00 ,  A61P1/12

CPC分类号： G01N33/56922 ,  A23L33/10 ,  A23L33/40 ,  A23V2002/00 ,  A61K31/702 ,  A61K45/06 ,  A61K47/61 ,  G01N33/566 ,  G01N33/56905 ,  G01N33/56911 ,  G01N33/56916 ,  Y02A50/473 ,  Y02A50/475 ,  A61K2300/00 ,  A23V2250/28 ,  A23V2200/32

摘要： The invention provides a therapeutical composition comprising purified fractions of compounds being or containing a pathogen-inhibiting oligosaccharide sequence for use as a medicament. The present invention especially describes an oligosaccharide-containing substance or receptor binding to diarrheagenic Escherichia coli and/or zoonotic Helicobacter species, and use thereof in, e.g., pharmaceutical, nutritional and other compositions for prophylaxis and treatment of conditions due to the presence of Escherichia coli and/or zoonotic Helicobacter species. The invention is also directed to the use of the receptors for diagnostics of Escherichia coli and/or zoonotic Helicobacter species.

摘要翻译： 本发明提供一种治疗组合物，包括化合物的纯化馏分是或含有用作药物的病原体 - 抑制寡糖序列。 本发明的爱特别描述物质或受体结合到致泻大肠杆菌和/或人畜共患螺杆菌种到含低聚糖，而在它们的使用，例如，药物，由于大肠杆菌的存在营养和其他的组合物用于预防和治疗的条件 和/或人畜共患螺杆菌种。 因此，本发明涉及使用所述受体的大肠杆菌和/或人畜共患螺杆菌种的诊断。

公开(公告)号：EP2272522A3

公开(公告)日：2011-04-20

申请号：EP09157883.1

申请日：2003-06-30

申请人： Glykos Finland Oy

发明人： Angström, Jonas ,  Teneberg, Susann ,  Saarinen, Juhani ,  Satomaa, Tero ,  Roche, Niamh ,  Natunen, Jari ,  Miller-Podraza, Halina ,  Karlsson, Karl-Anders ,  Abul-Milh, Maan

IPC分类号： A61K31/702 ,  A61K35/00 ,  A61P1/12

CPC分类号： G01N33/56922 ,  A23L33/10 ,  A23L33/40 ,  A23V2002/00 ,  A61K31/702 ,  A61K45/06 ,  A61K47/61 ,  G01N33/566 ,  G01N33/56905 ,  G01N33/56911 ,  G01N33/56916 ,  Y02A50/473 ,  Y02A50/475 ,  A61K2300/00 ,  A23V2250/28 ,  A23V2200/32

摘要： The invention provides a therapeutical composition comprising purified fractions of compounds being or containing a pathogen-inhibiting oligosaccharide sequence for use as a medicament. The present invention especially describes an oligosaccharide-containing substance or receptor binding to diarrheagenic Escherichia coli and/or zoonotic Helicobacter species, and use thereof in, e.g., pharmaceutical, nutritional and other compositions for prophylaxis and treatment of conditions due to the presence of Escherichia coli and/or zoonotic Helicobacter species. The invention is also directed to the use of the receptors for diagnostics of Escherichia coli and/or zoonotic Helicobacter species.